{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:55:44Z","timestamp":1792032944065,"version":"4.4.0"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Invasive fungal infections are associated with high morbidity in solid organ transplant recipients. Risk factor modification may help with preventative efforts. The objective of this study was to identify risk factors for the development of fungal infections within the first year following solid organ transplant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We searched for eligible articles through February 3, 2023. Studies published after January 1, 2001, that pertained to risk factors for development of invasive fungal infections in solid organ transplant were reviewed for inclusion. Of 3087 articles screened, 58 were included. Meta-analysis was conducted using a random-effects model to evaluate individual risk factors for the primary outcome of any invasive fungal infections and invasive candidiasis or invasive aspergillosis (when possible) within 1 y posttransplant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>We found 3 variables with a high certainty of evidence and strong associations (relative effect estimate \u2265 2) to any early invasive fungal infections across all solid organ transplant groups: reoperation (odds ratio [OR], 2.92; confidence interval [CI], 1.79-4.75), posttransplant renal replacement therapy (OR, 2.91; CI, 1.87-4.51), and cytomegalovirus disease (OR, 2.97; CI, 1.78-4.94). Both posttransplant renal replacement therapy (OR, 3.36; CI, 1.78-6.34) and posttransplant cytomegalovirus disease (OR, 2.81; CI, 1.47-5.36) increased the odds of early posttransplant invasive aspergillosis. No individual variables could be pooled across groups for invasive candidiasis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Several common risk factors exist for the development of any invasive fungal infections in solid organ transplant recipients. Additional risk factors for invasive candidiasis and aspergillosis may be unique to the pathogen, transplanted organ, or both.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004871","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T05:01:08Z","timestamp":1699851668000},"page":"970-984","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Risk Factors for Early Fungal Disease in Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis"],"prefix":"10.1097","volume":"108","author":[{"given":"Kelly M.","family":"Pennington","sequence":"first","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN."},{"name":"William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max J.","family":"Martin","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Hassan","family":"Murad","sequence":"additional","affiliation":[{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sanborn","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar A.","family":"Saddoughi","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Gerberi","sequence":"additional","affiliation":[{"name":"Department of Library Services, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve G.","family":"Peters","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN."},{"name":"William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymund R.","family":"Razonable","sequence":"additional","affiliation":[{"name":"William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN."},{"name":"Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassie C.","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN."},{"name":"William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN."},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/345441","article-title":"Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients.","volume":"36","author":"Singh","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0891-5520(02)00067-3","article-title":"Fungal infections in the recipients of solid organ transplantation.","volume":"17","author":"Singh","year":"2003","journal-title":"Infect Dis Clin North Am"},{"issue":"4 Suppl. 1","key":"R4-20250604","doi-asserted-by":"crossref","first-page":"S306","DOI":"10.1016\/j.healun.2015.01.862","article-title":"Mortality from aspergillosis after heart transplantation.","volume":"34","author":"Al-Kindi","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/ctr.12516","article-title":"Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis.","volume":"29","author":"Chong","year":"2015","journal-title":"Clin Transplant"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"e13568","DOI":"10.1111\/tid.13568","article-title":"Targeted caspofungin prophylaxis for invasive aspergillosis in high-risk liver transplant recipients, a single-center experience.","volume":"23","author":"Chakravarti","year":"2021","journal-title":"Transpl Infect Dis"},{"issue":"Suppl 1","key":"R7-20250604","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1093\/ofid\/ofw172.1881","article-title":"Risk stratification for targeted antifungal prophylaxis in adult liver transplant recipients.","volume":"3","author":"Dunn","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"Suppl 2","key":"R9-20250604","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the Intensive Care Unit Working Group.","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.healun.2011.01.701","article-title":"A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients.","volume":"30","author":"Husain","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/13693780701200372","article-title":"Fungal infections in solid organ transplantation.","volume":"45","author":"Silveira","year":"2007","journal-title":"Med Mycol"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2217\/fmb.12.28","article-title":"Invasive fungal infections in solid organ transplant recipients.","volume":"7","author":"Shoham","year":"2012","journal-title":"Future Microbiol"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/ajt.16935","article-title":"Risk factors of invasive fungal infections in liver transplant recipients: a systematic review and meta-analysis.","volume":"22","author":"Phoompoung","year":"2022","journal-title":"Am J Transplant"},{"issue":"4 Suppl","key":"R14-20250604","doi-asserted-by":"crossref","first-page":"S485","DOI":"10.1016\/j.healun.2020.01.050","article-title":"Risk factors of invasive fungal infections in heart and lung transplantation: systematic review and meta-analysis.","volume":"39","author":"Phoompoung","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/ajt.16248","article-title":"Risk factors for the development of invasive aspergillosis after kidney transplantation: systematic review and meta-analysis.","volume":"21","author":"Perez-Jacoiste Asin","year":"2021","journal-title":"Am J Transplant"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors.","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3 rating the quality of evidence.","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jclinepi.2019.12.023","article-title":"GRADE guidelines 28: use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks.","volume":"121","author":"Foroutan","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3102\/10769986030003261","article-title":"Bias and efficiency of meta-analytic variance estimators in the random-effects model.","volume":"30","author":"Viechtbauer","year":"2005","journal-title":"J Educational Behav Statistics"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1600-6143.2004.00390.x","article-title":"Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis.","volume":"4","author":"Munoz","year":"2004","journal-title":"Am J Transplant"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/01.tp.0000441088.01723.ee","article-title":"Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infection.","volume":"97","author":"Tissot","year":"2014","journal-title":"Transplantation"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"e13714","DOI":"10.1111\/tid.13714","article-title":"Epidemiology, risk factors, and association of antifungal prophylaxis on early invasive fungal infection in heart transplant recipients.","volume":"23","author":"Yetmar","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/cid\/civ103","article-title":"Invasive aspergillosis after kidney transplant: case-control study.","volume":"60","author":"Heylen","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1111\/ajt.13735","article-title":"Risk factors associated with early invasive pulmonary aspergillosis in kidney transplant recipients: results from a multinational matched case-control study.","volume":"16","author":"Lopez-Medrano","year":"2016","journal-title":"Am J Transplant"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/lt.20827","article-title":"Association of hepatic iron overload with invasive fungal infection in liver transplant recipients.","volume":"12","author":"Alexander","year":"2006","journal-title":"Liver Transpl"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/ajt.12993","article-title":"Targeted versus universal antifungal prophylaxis among liver transplant recipients.","volume":"15","author":"Eschenauer","year":"2015","journal-title":"Am J Transplant"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"e930117","DOI":"10.12659\/AOT.930117","article-title":"Invasive fungal infections after liver transplantation: a retrospective matched controlled risk analysis.","volume":"26","author":"Karadag","year":"2021","journal-title":"Ann Transplant"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"e12859","DOI":"10.1111\/tid.12859","article-title":"A simplified regimen of targeted antifungal prophylaxis in liver transplant recipients: a single-center experience.","volume":"20","author":"Lavezzo","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/myc.12041","article-title":"Pretransplant model for end stage liver disease score predicts posttransplant incidence of fungal infections after liver transplantation.","volume":"56","author":"Lichtenstern","year":"2013","journal-title":"Mycoses"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jiac.2015.11.005","article-title":"Epidemiology of invasive fungal infections after liver transplantation and the risk factors of late-onset invasive aspergillosis.","volume":"22","author":"Nagao","year":"2016","journal-title":"J Infect Chemother"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/lt.23467","article-title":"Invasive fungal infections following liver transplantation: incidence, risk factors, survival, and impact of fluconazole-resistant Candida parapsilosis (2003-2007).","volume":"18","author":"Raghuram","year":"2012","journal-title":"Liver Transpl"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s15010-008-8124-x","article-title":"A risk profile for invasive aspergillosis in liver transplant recipients.","volume":"37","author":"Rosenhagen","year":"2009","journal-title":"Infection"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00029330-200804010-00010","article-title":"Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation.","volume":"121","author":"Shi","year":"2008","journal-title":"Chin Med J (Engl)"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1751-2980.2011.00542.x","article-title":"Invasive fungal infection after liver transplantation: risk factors and significance of immune cell function monitoring.","volume":"12","author":"Zhou","year":"2011","journal-title":"J Dig Dis"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1086\/430602","article-title":"Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study.","volume":"41","author":"Gavalda","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/jof7080639","article-title":"The prediction and prognosis of fungal infection in lung transplant recipients-a retrospective cohort study in South Korea.","volume":"7","author":"Baek","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1097\/TP.0000000000000743","article-title":"The effectiveness of culture-directed preemptive anti-aspergillus treatment in lung transplant recipients at one year after transplant.","volume":"99","author":"Hosseini-Moghaddam","year":"2015","journal-title":"Transplantation"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/01.TP.0000437434.42851.d4","article-title":"Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis.","volume":"97","author":"Luong","year":"2014","journal-title":"Transplantation"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/cid\/ciz156","article-title":"Invasive fungal infection after lung transplantation: epidemiology in the setting of antifungal prophylaxis.","volume":"70","author":"Maziarz","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/1469-0691.12165","article-title":"Epidemiology, risk factors and impact on long-term pancreatic function of infection following pancreas-kidney transplantation.","volume":"19","author":"Herrero-Martinez","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"e13367","DOI":"10.1111\/ctr.13367","article-title":"A case-control study of the risk factors for developing aspergillosis following cardiac transplant.","volume":"32","author":"Cook","year":"2018","journal-title":"Clin Transplant"},{"key":"R44-20250604","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12650","article-title":"Invasive fungal infection after heart transplantation: a 7-year, single-center experience.","volume":"19","author":"Echenique","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.healun.2014.09.036","article-title":"Risk factors for invasive fungal disease in heart transplant recipients.","volume":"34","author":"Rabin","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1016\/j.transproceed.2010.10.010","article-title":"Incidence and risk factors for pulmonary mycosis in kidney transplantation.","volume":"42","author":"Chen","year":"2010","journal-title":"Transplant Proc"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.amjms.2019.10.008","article-title":"Risk factors associated with invasive fungal infections in kidney transplant patients.","volume":"359","author":"Leitheiser","year":"2020","journal-title":"Am J Med Sci"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cmi.2017.06.016","article-title":"Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation.","volume":"24","author":"Lopez-Medrano","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"e13289","DOI":"10.1111\/ctr.13289","article-title":"The feared five fungal infections in kidney transplant recipients: a single-center 20-year experience.","volume":"32","author":"Parajuli","year":"2018","journal-title":"Clin Transplant"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11046-015-9875-4","article-title":"Invasive fungal infections in renal transplant recipients: epidemiology and risk factors.","volume":"180","author":"Sahin","year":"2015","journal-title":"Mycopathologia"},{"key":"R51-20250604","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s10096-020-03871-2","article-title":"Risk factors for development and mortality of invasive pulmonary Aspergillosis in kidney transplantation recipients.","volume":"39","author":"Seok","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R52-20250604","doi-asserted-by":"crossref","first-page":"196","DOI":"10.6002\/ect.2019.0010","article-title":"Invasive fungal infections with good survival following liver transplant: a single-center experience from a developing country.","volume":"18","author":"Ebrahimi","year":"2020","journal-title":"Exp Clin Transplant"},{"key":"R53-20250604","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1053\/jlts.2002.36239","article-title":"Risk factors for invasive aspergillosis in liver transplant recipients.","volume":"8","author":"Fortun","year":"2002","journal-title":"Liver Transpl"},{"key":"R54-20250604","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1097\/01.TP.0000065178.93741.72","article-title":"Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study.","volume":"75","author":"Husain","year":"2003","journal-title":"Transplantation"},{"key":"R55-20250604","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1620\/tjem.209.207","article-title":"Risk factors and impact of beta-D glucan on invasive fungal infection for the living donor liver transplant recipients.","volume":"209","author":"Kawagishi","year":"2006","journal-title":"Tohoku J Exp Med"},{"key":"R56-20250604","doi-asserted-by":"crossref","first-page":"e13361","DOI":"10.1111\/tid.13361","article-title":"Epidemiology and risk factors for invasive fungal disease in liver transplant recipients in a tertiary transplant center.","volume":"22","author":"Lum","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"R57-20250604","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00534-011-0423-4","article-title":"The risk factors of fungal infection in living-donor liver transplantations.","volume":"19","author":"Ohkubo","year":"2012","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"Suppl 1","key":"R58-20250604","first-page":"110","article-title":"Invasive fungal infections in liver transplant recipients.","volume":"12","author":"Ok Atilgan","year":"2014","journal-title":"Exp Clin Transplant"},{"key":"R59-20250604","doi-asserted-by":"crossref","first-page":"E454","DOI":"10.1111\/ctr.12129","article-title":"Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era.","volume":"27","author":"Saliba","year":"2013","journal-title":"Clin Transplant"},{"key":"R60-20250604","doi-asserted-by":"crossref","first-page":"e12898","DOI":"10.1111\/tid.12898","article-title":"Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study.","volume":"20","author":"Neofytos","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"R61-20250604","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1399-3062.2009.00371.x","article-title":"Candidemia following solid organ transplantation in the era of antifungal prophylaxis: the Australian experience.","volume":"11","author":"van Hal","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"R62-20250604","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/j.transproceed.2012.09.059","article-title":"Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients.","volume":"44","author":"Bodro","year":"2012","journal-title":"Transplant Proc"},{"key":"R63-20250604","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/605445","article-title":"Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome.","volume":"200","author":"Singh","year":"2009","journal-title":"J Infect Dis"},{"key":"R64-20250604","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.3760\/cma.j.issn.0366-6999.20130252","article-title":"Pneumonia relevant to lung transplantation and pathogen distribution.","volume":"126","author":"He","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"R65-20250604","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10096-007-0376-3","article-title":"Aspergillus infection in lung transplant patients: incidence and prognosis.","volume":"26","author":"Iversen","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R66-20250604","first-page":"181","article-title":"Fungal infections in lung transplantation. Incidence, risk factors and prognostic significance.","volume":"18","author":"Ruffini","year":"2001","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R67-20250604","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1469-0691.2005.01128.x","article-title":"Aspergillus infections in lung transplant recipients: risk factors and outcome.","volume":"11","author":"Sole","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"R68-20250604","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/ajt.13535","article-title":"Infectious complications following small bowel transplantation.","volume":"16","author":"Silva","year":"2016","journal-title":"Am J Transplant"},{"key":"R69-20250604","doi-asserted-by":"crossref","first-page":"e13812","DOI":"10.1111\/tid.13812","article-title":"Epidemiology of candidemia in lung transplant recipients and risk factors for candidemia in the early posttransplant period in the absence of universal antifungal prophylaxis.","volume":"24","author":"Marinelli","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"R70-20250604","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/myc.13436","article-title":"Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients: a comparative study of two consecutive periods.","volume":"65","author":"Lopez-Medrano","year":"2022","journal-title":"Mycoses"},{"key":"R71-20250604","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jiac.2021.09.020","article-title":"Risk factors of breakthrough aspergillosis in lung transplant recipients receiving itraconazole prophylaxis.","volume":"28","author":"Katada","year":"2022","journal-title":"J Infect Chemother"},{"key":"R72-20250604","doi-asserted-by":"crossref","first-page":"718747","DOI":"10.3389\/fmed.2021.718747","article-title":"Epidemiology and prognosis of invasive fungal disease in Chinese lung transplant recipients.","volume":"8","author":"Ju","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R73-20250604","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/cid\/ciac927","article-title":"Risk factors and outcomes of invasive Aspergillosis in kidney transplant recipients: a case-control study of USRDS data.","volume":"76","author":"Friedman","year":"2023","journal-title":"Clin Infect Dis"},{"key":"R74-20250604","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.healun.2018.02.006","article-title":"A strategy for prevention of fungal infections in lung transplantation: role of bronchoalveolar lavage fluid galactomannan and fungal culture.","volume":"37","author":"Husain","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"R75-20250604","doi-asserted-by":"crossref","first-page":"e13085","DOI":"10.1111\/tid.13085","article-title":"Epidemiology of invasive fungal infections in lung transplant recipients in Western Australia.","volume":"21","author":"Chang","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"R76-20250604","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.healun.2018.06.008","article-title":"Clinical risk factors for invasive aspergillosis in lung transplant recipients: results of an international cohort study.","volume":"37","author":"Aguilar","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"R77-20250604","doi-asserted-by":"crossref","first-page":"e16179","DOI":"10.1097\/MD.0000000000016179","article-title":"Invasive fungal infection in liver transplant recipients in a prophylactic era: a multicenter retrospective cohort study in Korea.","volume":"98","author":"Kim","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R78-20250604","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/tid.12560","article-title":"Antifungal prophylaxis in liver transplant recipients: one size does not fit all.","volume":"18","author":"Giannella","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"R79-20250604","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1111\/ajt.13837","article-title":"Clinical presentation and determinants of mortality of invasive pulmonary Aspergillosis in kidney transplant recipients: a multinational cohort study.","volume":"16","author":"Lopez-Medrano","year":"2016","journal-title":"Am J Transplant"},{"key":"R80-20250604","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group.","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"R81-20250604","first-page":"390","article-title":"Risk factors for early invasive fungal infection after heart transplantation.","volume":"12","author":"Tissot","year":"2012","journal-title":"Am J Transplant"},{"key":"R82-20250604","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.healun.2021.09.014","article-title":"Risk factors of invasive fungal infections in lung transplant recipients: a systematic review and meta-analysis.","volume":"41","author":"Phoompoung","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"R83-20250604","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.transproceed.2021.05.006","article-title":"Efficacy and safety according to the dose of valganciclovir for cytomegalovirus prophylaxis in transplantation: network meta-analysis using recent data.","volume":"53","author":"Lee","year":"2021","journal-title":"Transplant Proc"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004871","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:07:55Z","timestamp":1749060475000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004871","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,13]]}}}